Literature DB >> 25150487

Decreased levels of serum Angiotensin-(1-7) in patients with pulmonary arterial hypertension due to congenital heart disease.

Hailong Dai1, Yongfei Gong2, Zhicheng Xiao3, Xuefeng Guang4, Xiaolong Yin5.   

Abstract

Entities:  

Keywords:  Angiotensin-(1–7); Congenital heart disease; Pulmonary arterial hypertension

Mesh：

Substances：

Year:  2014        PMID： 25150487     DOI： 10.1016/j.ijcard.2014.08.021

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  8 in total

1.  ACE2-angiotensin-(1-7)-Mas axis might be a promising therapeutic target for pulmonary arterial hypertension.

Authors:  Hailong Dai; Lihong Jiang; Zhicheng Xiao; Xuefeng Guang
Journal:  Nat Rev Cardiol       Date:  2015-05-05       Impact factor: 32.419

Review 2.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 3.  ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy.

Authors:  Colleen T Cole-Jeffrey; Meng Liu; Michael J Katovich; Mohan K Raizada; Vinayak Shenoy
Journal:  J Cardiovasc Pharmacol       Date:  2015-12       Impact factor: 3.105

Review 4.  Emerging therapeutics in pulmonary hypertension.

Authors:  Matthew K Hensley; Andrea Levine; Mark T Gladwin; Yen-Chun Lai
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-01       Impact factor: 5.464

Review 5.  Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19.

Authors:  Tomas Rajtik; Peter Galis; Linda Bartosova; Ludovit Paulis; Eva Goncalvesova; Jan Klimas
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

6.  Unique Pulmonary Hypertension in Young Children: A Case Series Study.

Authors:  I-Chen Chen; Hsiu-Lin Chen; Yi-Ching Liu; Yen-Hsien Wu; Shih-Hsing Lo; Jong-Hau Hsu; Hsin-Ling Yin; Jui-Sheng Hsu; Bin-Nan Wu; Zen-Kong Dai
Journal:  Children (Basel)       Date:  2022-07-17

7.  COVID-19 and the pulmonary vascular injury.

Authors:  Hai-Long Dai; Xue-Feng Guang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Oct-Dec       Impact factor: 1.636

8.  The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.

Authors:  I-Chen Chen; Jao-Yu Lin; Yi-Ching Liu; Chee-Yin Chai; Jwu-Lai Yeh; Jong-Hau Hsu; Bin-Nan Wu; Zen-Kong Dai
Journal:  Int J Med Sci       Date:  2020-09-16       Impact factor: 3.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.